High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Atherosclerosis

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0021-9150(03)00006-6PMID 12801602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for deficiency of high density lipoprotein lecithin: cholesterol acyltransferase activity (alpha-LCAT) in fish eye disease.

  2009cited by this paper
• Coronary drug project: Experience with niacin

  2005cited by this paper
• Recombinant Apolipoprotein A-IMilano Infusion Into Rabbit Carotid Artery Rapidly Removes Lipid From Fatty Streaks

  2002cited by this paper
• Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study

  2002cited by this paper
• Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.

  2002cited by this paper
• Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages

  2002cited by this paper
• Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol

  2002cited by this paper
• High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Moderate alcohol consumption: effects on lipids and cardiovascular disease risk

  2001cited by this paper
• Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis.

  2001cited by this paper
• The role of fibric acids in atherosclerosis

  2001cited by this paper
• Cardiovascular Status of Carriers of the Apolipoprotein A-IMilano Mutant: The Limone sul Garda Study

  2001cited by this paper
• An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

  2001cited by this paper
• Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1*

  2001cited by this paper
• ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.

  2001cited by this paper
• Handbook of Lipoprotein Testing

  2001cited by this paper
• Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

  2001cited by this paper
• Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

  2001cited by this paper
• Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.

  2001cited by this paper
• High-Density Lipoproteins and Endothelial Function

  2001cited by this paper
• High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

  2001cited by this paper
• Race differences in the response of postheparin plasma lipoprotein lipase and hepatic lipase activities to endurance exercise training in men: results from the HERITAGE Family Study.

  2001cited by this paper
• Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.

  2001cited by this paper
• Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia.

  2001cited by this paper
• Cholesteryl ester transfer protein, high density lipoprotein and arterial disease

  2001cited by this paper
• Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis

  2000cited by this paper
• Relationship between Expression Levels and Atherogenesis in Scavenger Receptor Class B, Type I Transgenics*

  2000cited by this paper
• Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.

  2000cited by this paper
• Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression.

  2000cited by this paper
• Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice

  2000cited by this paper
• A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

  2000cited by this paper
• Nonpharmacologic management of low levels of high-density lipoprotein cholesterol.

  2000cited by this paper
• Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

  2000cited by this paper
• Remodelling of high density lipoproteins by plasma factors.

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.

  1999cited by this paper
• The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

  1999cited by this paper
• Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

  1999cited by this paper
• Comparative effects of simvastatin and cholestyramine on plasma lipoproteins and CETP in humans.

  1999cited by this paper
• High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway

  1999cited by this paper
• Cholesteryl Ester Transfer Protein Corrects Dysfunctional High Density Lipoproteins and Reduces Aortic Atherosclerosis in Lecithin Cholesterol Acyltransferase Transgenic Mice*

  1999cited by this paper
• Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

  1999cited by this paper
• Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.

  1999cited by this paper
• Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

  1999cited by this paper
• Mechanism of action of fibrates on lipid and lipoprotein metabolism.

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Oxidation of High Density Lipoproteins

  1998cited by this paper
• Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

  1998cited by this paper
• A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.

  1998cited by this paper
• The effect of smoking on post‐heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma

  1998cited by this paper
• Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits*

  1998cited by this paper
• High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase

  1997cited by this paper
• Genetic Variant Showing a Positive Interaction With β-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients: The Ser447-Stop Substitution in the Lipoprotein Lipase Gene

  1997cited by this paper
• HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL.

  1997cited by this paper
• Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: animal studies.

  1997cited by this paper
• Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.

  1997cited by this paper
• Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: human studies.

  1997cited by this paper
• The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes.

  1997cited by this paper
• Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.

  1996cited by this paper
• Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.

  1996cited by this paper
• High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells.

  1996cited by this paper
• Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cells.

  1996cited by this paper
• West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.

  1996cited by this paper
• Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools.

  1995cited by this paper
• Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Monounsaturated versus polyunsaturated dietary fat and serum lipids. A meta-analysis.

  1995cited by this paper
• Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.

  1995cited by this paper
• Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic.

  1995cited by this paper
• Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction.

  1995cited by this paper
• High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

  1995cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• HDL, its enzymes and its potential to influence lipid peroxidation

  1995cited by this paper
• Deficiency of lecithin:cholesterol acyltransferase due to compound heterozygosity of two novel mutations (Gly33Arg and 30 bp ins) in the LCAT gene.

  1995cited by this paper
• Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.

  1995cited by this paper
• HDL, its enzymes and its potential to influence lipid peroxidation.

  1995cited by this paper
• Role of an N-ethylmaleimide-sensitive factor in the selective cellular uptake of low-density lipoprotein free cholesterol.

  1995cited by this paper
• A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis

  1995cited by this paper
• Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma.

  1995cited by this paper
• Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins.

  1994cited by this paper
• Effects of Exercise Training on Plasma Lipids and Lipoproteins

  1994cited by this paper
• Cholesteryl ester transfer protein gene: two common mutations and their effect on plasma high-density lipoprotein cholesterol content.

  1994cited by this paper
• Modulators of oxidized LDL-induced hyperadhesiveness in human endothelial cells.

  1994cited by this paper
• High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor.

  1994cited by this paper
• Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

  1994cited by this paper
• Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.

  1994cited by this paper
• HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity.

  1994cited by this paper
• 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma.

  1994cited by this paper

• Predictive Value of Monocyte to High-Density Lipoprotein Cholesterol Ratio for Target Lesion Revascularization in Patients With Drug-Eluting Stent Implantation

  2025cites this paper
• Investigation into the molecular mechanisms of biomarkers in psoriasis vulgaris with reduced high-density lipoprotein levels based on bulk transcriptome sequencing data.

  2024cites this paper
• Overexpression of CuZn superoxide dismutase improves high-density lipoprotein function in swine.

  2024cites this paper
• Monocyte to high-density lipoprotein cholesterol ratio predicts restenosis of drug-eluting stents in patients with unstable angina pectoris

  2024cites this paper
• Relationship between the cholesterol and triglyceride content of lipoprotein subclasses and carotid intima-media thickness: a cross-sectional population-based study.

  2023cites this paper
• Interaction between SIDT2 and ABCA1 Variants with Nutrients on HDL-c Levels in Mexican Adults

  2023cites this paper
• The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy

  2022cites this paper
• Serum Cholesterol Efflux Capacity in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

  2022cites this paper
• Molecular Genetic Mechanisms in Age-Related Macular Degeneration

  2022cites this paper
• Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy.

  2022cites this paper
• Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.

  2021cites this paper
• Effets de la corticothérapie systémique sur le métabolisme des HDL

  2020cites this paper
• Cardiovascular Risk Reduction With Icosapent Ethyl: A Systematic Literature Review

  2020cites this paper
• Effects of Coronary Angioplasty on Inflammatory Markers and Lipid Profile in Patients with Cardiovascular Disease

  2020cites this paper
• Lipoproteins in Atherosclerosis Process.

  2019cites this paper
• Association of High-Density Lipoprotein Subclasses with Carotid Intima-Media Thickness: Shimane CoHRE Study

  2018cites this paper
• Determinants of cholesterol efflux capacity in humans.

  2018cites this paper
• Specific cholesterol binding drives drastic structural alterations in Apolipoprotein A1

  2018cites this paper
• HDL cholesterol efflux capacity and cholesteryl ester transfer are associated with body mass, but are not changed by diet-induced weight loss: A randomized trial in abdominally obese men.

  2018cites this paper
• Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk.

  2018cites this paper
• Lipid transfers to HDL are diminished in long-term bedridden patients: association with low HDL-cholesterol and increased inflammatory markers

  2017cites this paper
• Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study.

  2017cites this paper
• Cardioprotective Effect of Mango and Kinnow Peel Extracts on Doxorubicin-induced Cardiotoxicity in Albino Rats

  2017cites this paper
• The impact of cranberry (Vaccinium macrocarpon) and cranberry products on each component of the metabolic syndrome: a review

  2017cites this paper
• Monocyte to HDL ratio in prediction of BMS restenosis in subjects with stable and unstable angina pectoris.

  2016cites this paper
• Apolipoprotein C-III Nanodiscs Studied by Site-Specific Tryptophan Fluorescence.

  2016cites this paper
• Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status.

  2016cites this paper
• Associations between follicular fluid high density lipoprotein particle components and embryo quality among in vitro fertilization patients

  2016cites this paper
• Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.

  2016cites this paper
• Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects

  2016cites this paper
• The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality

  2015cites this paper
• Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease

  2015cites this paper
• HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis.

  2015cites this paper
• HYPOLIPIDEMIC AND ANTI INFLAMMATORY ACTIVITY OF BOERHAAVIA DIFFUSA IN ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTED RATS

  2015cites this paper
• Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL

  2015cites this paper
• Regulation of Reverse Cholesterol Transport by Micrornas and impact of Diet and Xenobiotics.

  2015cites this paper
• Learning from biology: synthetic lipoproteins for drug delivery.

  2015cites this paper
• Effects of heavy alcohol intake on lipoproteins, adiponectin and cardiovascular risk

  2014cites this paper
• Antiatherosclerotic Effect of Canariumodontophyllum Miq . Fruit Parts in Rabbits Fed High Cholesterol Diet

  2014cites this paper
• Subfractions and subpopulations of HDL: an update.

  2014cites this paper
• HDL genetic defects.

  2014cites this paper
• HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection

  2014cites this paper
• Genes associated with low serum high-density lipoprotein cholesterol.

  2014cites this paper
• High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.

  2014cites this paper
• The effect of plant-derived oleanolic acid on selected markers of lipid metabolism and insulin signalling pathway in streptozotocin-induced diabetic rats.

  2014cites this paper
• Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia.

  2014cites this paper
• Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease

  2014cites this paper
• Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology.

  2014cites this paper
• Mendelian Disorders of High-Density Lipoprotein Metabolism

  2014cites this paper
• A review of paradoxical HDL-C responses to fenofibrate, illustrated by a case report.

  2014cites this paper
• Étude de la Structure-Fonction du Prosegment et du domaine CHRD de la PCSK9 humaine

  2014cites this paper
• Atherogenic Indices and HDL Particle Size as Laboratory Parameters to Evaluate Cardiovascular Risk in the Presence of Dyslipidemia

  2014cites this paper
• Does plasma HDL-C concentration interact with whole-body cholesterol metabolism?

  2013cites this paper
• -Induced Inflammatory Response in Human α Lipoproteins 3 Fail to Inhibit the TNF- The 15-Lipoxygenase-Modified High Density

  2013cites this paper
• Stability of discoidal high-density lipoprotein particles

  2013cites this paper
• Dysfunctional HDL-cholesterol: a potential link between high levels of HDL-cholesterol and cardiovascular disease?

  2013cites this paper
• Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.

  2013cites this paper
• Beneficial Effect of Dietary Squalene Supplementation on Experimentally Induced Cardiomyopathy in Rats

  2013cites this paper
• ATIVIDADE DA PARAOXONASE / ARIL-ESTERASE (PON) E INCORPORAÇÃO DE FOSFOLIPÍDEOS EM PARTÍCULAS DE HDL NA HIPERTRIGLICERIDEMIA HUMANA

  2013cites this paper
• High-density Lipoprotein Subclasses and Risk of Stroke and its Subtypes in Japanese Population: The Circulatory Risk in Communities Study

  2013cites this paper
• Lipid signaling in the endothelium.

  2013cites this paper
• Medicinal Plants in the Prevention and Treatment of Chronic Diseases

  2012cites this paper
• Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study.

  2012cites this paper
• Antiatherosclerotic Effect of Canarium odontophyllum Miq. Fruit Parts in Rabbits Fed High Cholesterol Diet

  2012cites this paper
• High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without / with intensive insulin therapy.

  2012cites this paper
• Revealing structural and dynamical properties of high density lipoproteins through molecular simulations

  2012cites this paper
• APO AI-promotor polymorphism influences baseline HDL-cholesterol and apolipoprotein AI concentration in healthy men

  2012cites this paper
• The Influence of Initial Blood Triglyceride Concentrations on the Change in Blood Lipids Following an Acute Bout of Exercise

  2012influential citation
• Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study

  2012cites this paper
• Influência da obesidade em adolescentes sobre a atividade da paraoxonase (PON1) e o tamanho da Lipoproteína de Alta Densidade (HDL)

  2012cites this paper
• Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice.

  2012cites this paper
• Reverse cholesterol transport in familial hypercholesterolemia

  2012cites this paper
• Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors.

  2012cites this paper
• Role of Lipoproteins in Carcinogenesis and in Chemoprevention

  2012influential citation
• Apolipoprotein A-II-mediated Conformational Changes of Apolipoprotein A-I in Discoidal High Density Lipoproteins*

  2012cites this paper
• Relation between blood lipid levels and diet and characterization of food choices in children with familial hypercholesterolemia

  2012cites this paper
• INCORPORAÇÃO E ESTERIFICAÇÃO DO COLESTEROL NA LIPOPROTEÍNA DE ALTA DENSIDADE (HDL): AVALIAÇÃO DE BIOMARCADORES PLASMÁTICOS E DO DIAGNÓSTICO POR IMAGEM (ECOGRAFIA VASCULAR COM DOPPLER) RELACIONADOS COM A DOENÇA ATEROGÊNICA DE CARÓTIDAS EXTRACRANIANAS E ARTÉRIAS VERTEBRAIS

  2012cites this paper
• Preparation and Characterization of a Lovastatin-Loaded Protein-Free Nanostructured Lipid Carrier Resembling High-Density Lipoprotein and Evaluation of its Targeting to Foam Cells

  2011cites this paper
• HIGH-DENSITY LIPOPROTEINS AND APOLIPOPROTEIN A-I WITH AORTIC ENDOTHELIAL CELLS

  2011cites this paper
• Total cholesterol content of erythrocyte membranes in acute coronary syndrome: correlation with apolipoprotein A-I and lipoprotein (a)

  2011cites this paper
• Emerging options in the treatment of dyslipidemias: a bright future?

  2011cites this paper
• Genetically Elevated Apolipoprotein A-I, High-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease

  2011cites this paper
• Blood Pressure-Lowering Response to Amlodipine as a Determinant of the Antioxidative Activity of Small, Dense HDL3

  2011cites this paper
• Imaging apolipoprotein AI in vivo

  2011cites this paper
• Interactions of high-density lipoproteins and apolipoprotein A-I with aortic endothelial cells

  2011cites this paper
• Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: a monozygotic twin pair study.

  2011cites this paper
• A novel fluorogenic substrate for the measurement of endothelial lipase activity

  2011cites this paper
• Adeno-associated virus serotype 2 mediated transduction and coexpression of the human apoAI and SR-BI gene in HepG2 cells

  2011cites this paper
• The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

  2011cites this paper
• High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.

  2010cites this paper
• Cinética plasmática do colesterol livre e do colesterol esterificado e transferência in vitro de lípides para a HDL, utilizando uma nanoemulsão lipídica artificial, em indivíduos com intolerância à glicose

  2010cites this paper
• Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response

  2010cites this paper
• The Role of High-Density Lipoproteins in Reducing the Risk of Vascular Diseases, Neurogenerative Disorders, and Cancer

  2010cites this paper
• Thematic Review Series: Genetics of Human Lipid Diseases Genetic causes of high and low serum HDL-cholesterol

  2010cites this paper
• HDL-cholestérol et risque cardiovasculaire : au-delà du LDL !

  2010cites this paper
• The prognostic value of biomarkers after a premature myocardial infarction.

  2010cites this paper
• Dysfunctional High-Density Lipoprotein and Atherosclerosis

  2010cites this paper
• Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients.

  2010cites this paper
• High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.

  2010cites this paper
• High density lipoprotein-anionic peptide factor effect on reverse cholesterol transport in type 2 diabetic patients with and without coronary artery disease.

  2010cites this paper